Zealthy
$151 a month for compounded semaglutide, or $25 if it gets your insurance to say yes.
- Medication
- both
- Commitment
- month-to-month
- Insurance
- insurance option
- Price checked
- 2026-09-22
Read from Zealthy's own page on 20 Aug 2026: compounded semaglutide from $151 a month with supplies included, and brand-name Ozempic, Wegovy, Zepbound or Mounjaro from $25 a month when it succeeds in getting your insurance to cover them. The page reads "Semaglutide as low as $151/month". Both figures are 'as low as'. The page carries a "$96 off — Last Chance: Sale ends soon" banner that was still running on 11 September 2026, three weeks after the 21 August end date it first gave.
What this page used to say
- 2026-09-11 — A drawback that no longer stood. Was: A countdown sale on a prescription drug — $96 off, 'last chance', ending 21 August — is a retail tactic, not a price. Now: A "$96 off — Last Chance: Sale ends soon" banner, still running on 11 September 2026 after the page said it would end on 21 August, is a retail tactic rather than a price.
- 2026-09-11 — A sale described as ending. Was: A $96 discount the page said ends 21 August 2026. Now: The same banner, still running on 11 September 2026.
How this monthly figure is built
One price covering medication.
What does Zealthy actually charge?
halfrx records Zealthy at $151 a month all-in, read from its own published page on 2026-09-22. What it costs once titrated is not published, which is a fact about the seller rather than a gap in the data. It runs month to month. It carries one flag on this site: FDA warning letter. It scores 4.1 out of 10 on a published formula that is arithmetic over the facts on this page, not an editor's opinion. Insurance is optional here, so the cash figure and the covered figure are different questions. The program includes clinical care and dispensing rather than a prescription alone. The page rests on 1 cited source, at least one of them a manufacturer, regulator or journal. Anything past 45 days without a re-check is marked stale here rather than quietly aging. Molecules: semaglutide, tirzepatide.
Tracked since 2026-08-20. Last corrected on 2026-09-11 — see what this page used to say, above.
No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price
What is good about Zealthy?
- +$151 a month with supplies included is at the cheap end of compounded semaglutide, and the page prints the figure rather than hiding it behind a quiz.[1]
- +It works the insurance route as well as the cash one — the $25 figure is what a covered brand prescription costs, and the company says it handles the paperwork.[1]
- +No lock-in: the program is billed monthly.[1]
What are the downsides of Zealthy?
- −Compounded semaglutide is not an FDA-approved product; it is a copy made under the pharmacy-compounding exemption, and the legal ground under it has been moving since the shortage ended.[1]
- −'As low as' does what it always does — the price rises with the dose, and what a maintenance dose costs is not published.[1]
- −The $25 figure depends entirely on your plan covering a brand GLP-1, which most commercial plans no longer do for obesity.[1]
- −A "$96 off — Last Chance: Sale ends soon" banner, still running on 11 September 2026 after the page said it would end on 21 August, is a retail tactic rather than a price.[1]
How this score is built
- 0.0/2.5Cost — publishes titration pricing only — what you pay once titrated is not published, so no points
- 1.2/2.5Medication — compounded medication, which the FDA does not review and which a court order can stop
- 1.0/1What they supply — strongest molecule offered: semaglutide, tirzepatide
- 0.8/1Commitment — month-to-month
- 1.0/1Care around the prescription — coaching, titration support and insurance help included
- 0.0/2Conduct — −2.3: compounding legal risk −0.8, FDA warning letter −1.5
Capped at 4.5: an active regulator action or a failing BBB grade limits the score whatever else it earns.
The full formula →Who compounds it
Names no compounding pharmacy anywhere this site could read. Read 2026-09-10 across /. Every seller audited the same way →
The public record
Lawsuits, regulator actions, FDA warning letters and BBB grade, each with the document behind it. Is Zealthy legit? →
Sources
Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.
The registers and documents behind this page
The public record on Zealthy is the result of searching these. They are named so the search can be repeated.
- Warning letters, U.S. Food and Drug Administration — The register searched for every seller on this site. A letter found here is linked from the seller's page to the original.
- Cases and proceedings, Federal Trade Commission — The register searched for advertising and billing actions against a seller.
Everything on Zealthy
- Zealthy price and terms →
- Is Zealthy legit? →
- semaglutide: every product and price →
- tirzepatide: every product and price →
- LillyDirect: the seller →
- Ivim Health: the seller →
- Mochi Health: the seller →
- CVS MinuteClinic: the seller →
- Henry Meds: the seller →
- Noom Med: the seller →
- Shed: the seller →
- Walgreens Weight Management: the seller →